Abstract:Abstract Purpose This study aimed at the development of a regulatory strategy for compliance of laboratory-developed tests (LDTs) with requirements of the Regulation (EU) 2017/746 (“EU-IVDR”) under consideration of international requirements for LDTs as established in major regulatory regions. Furthermore, it was analysed in how far elements of current LDT regulation could qualify for an internationally harmonised concept ensuring quality, safety and performance of LDTs. Methods A review of regulatory literature including legislation as well as guidance documents was performed. The regulatory strategy was adapted from international guidance concepts used for commercially marketed IVD. It was then applied to the example of a large medical laboratory in the EU. A high-level comparison was conducted to identify gaps and matches between the different international regulatory requirements for LDTs. Results A four-step strategy for compliance of LDTs with the EU IVDR was implemented in an exemplary medical laboratory. On the basis of an internationally used LDT definition, LDTs constitute nearly 50% of the total IVD devices used in the laboratory. While an ISO 15189-compliant QMS is a major component, it should be accompanied by the application of appropriate processes for risk management, performance evaluation and continuous monitoring of LDTs. At least six criteria represent common characteristics of a potential, internationally convergent concept for the regulation/standardization of LDTs. Conclusions This study confirms the impact of LDTs for individualized and innovative medical laboratory testing. Prerequisites for LDT use as especially given by the IVDR and missing interpretation in the EU with regard to the scope of LDT definition, the application of standards and the extent of documentation for LDTs currently lead to uncertainties for both laboratories and regulatory bodies responsible for LDT oversight. The characteristics identified as common criteria for ensuring quality, safety and performance of LDTs may be considered as central elements of future international consensus guidance.

Metabolomic Laboratory-Developed Tests: Current Status and Perspectives

Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation])

Quantitative tandem mass spectrometry in the clinical laboratory: Regulation and opportunity for validation of laboratory developed tests

Metabolomics analysis for biomarker discovery: advances and challenges

The Future of Laboratory-Developed Tests in Hemostasis Laboratories

Metabonomics: a useful tool for the future surgeon

A global perspective on the status of clinical metabolomics in laboratory medicine – a survey by the IFCC metabolomics working group

Advances in high throughput LC/MS based metabolomics: A review

Clinical metabolomics: Useful insights, perspectives and challenges

(Pre)Clinical Metabolomics Analysis

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics platforms to characterize inborn errors of metabolism.

The Role of Laboratory Developed Tests in the Development of Precision Medicine and Clinical Experimental Diagnosis

Metabolomics: a review of liquid chromatography mass spectrometry-based methods and clinical applications

Challenges in the Metabolomics-Based Biomarker Validation Pipeline

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications

FDA's proposed rule for the regulation of laboratory-developed tests

Current situation in laboratory developed tests supervision

Clinical metabolomics: current state and prospects in Russia

Untargeted Metabolomic Analysis for the Clinical Screening of Inborn Errors of Metabolism

Recent Development in Liquid Chromatography/Mass Spectrometry and Emerging Technologies for Metabolite Identification

Metabolomics in clinical and forensic toxicology, sports anti‐doping and veterinary residues